If you run a peptide business, you’ve probably noticed something: most accountants don’t really get your world. Not because the accounting is exotic. But because the business model, fast-growing, direct-to-consumer, operating in a regulatory gray area, dealing with payment processors that treat you like a liability creates a specific set of financial infrastructure challenges that most traditional accounting firms haven’t seen up close. We have. Not always in peptides specifically, but in businesses that share the same DNA. Nutraceuticals, cannabis, high-risk DTC. The financial problems are remarkably consistent.
Here’s what we see most often and what to actually do about it.
Problem One: Payment Processor Instability
This is the one that hits hardest and fastest.
Peptide businesses operate in a category that traditional payment processors are uncomfortable with. That means higher fees, stricter terms, sudden account holds, and terminations that arrive without warning and at the worst possible moment. We’ve watched this play out with clients in adjacent spaces, an account flagged, funds held, the business scrambling to make payroll while the processor “reviews” the situation. It’s disruptive, expensive, and entirely predictable if you know it’s coming.
What to do: don’t rely on a single processor. Build redundancy into your payment infrastructure before you need it. Know which high-risk processors serve your category, what their terms actually are, and what your backup plan looks like if your primary account gets flagged. Having that plan in place before something breaks is the difference between a bad week and a crisis.
Problem Two: Cash Flow Timing
Fast-growing DTC businesses have a cash flow paradox: revenue is coming in, but cash always feels tight. The reason is usually timing. Revenue comes in fast, sometimes faster than you can spend it. But expenses scale with growth, often faster than revenue does. Inventory (if you hold it), marketing spend, fulfillment, staffing, all of it demands cash now, while revenue recognition and actual cash receipts don’t always line up cleanly. Add payment processor holds to the mix, funds sitting in review while your bills keep coming and the timing gap gets worse.
What to do: build a rolling cash flow forecast. Know what’s coming in, what’s going out, and when. A simple 13-week cash flow model, updated weekly, gives you enough visibility to make good decisions instead of reactive ones. And get a business line of credit established before you need it. Banks extend credit to businesses that are doing fine. They’re much harder to work with when you’re already in a crunch.
Problem Three: Personal and Business Finances Mixed Together
This one is almost universal in early-stage businesses, and peptide companies are no exception.
The founder starts the business, uses their personal accounts to get things moving, and somewhere along the way the lines blur. Personal expenses flow through the business. Business revenue lands in personal accounts. The owner’s comp is whatever’s left after bills get paid. It feels manageable because the business is small and the founder knows where everything is. But it creates real problems: inaccurate financial statements, tax exposure, difficulty getting financing, and a business that can’t be evaluated on its own merits because it’s financially entangled with the owner’s personal life.
What to do: separate everything. Business bank account, business credit card, business payment processor. Pay yourself a salary or owner’s draw on a consistent schedule. The sooner you draw a clean line between personal and business finances, the easier everything else becomes; taxes, financing, valuation, eventual sale.
Problem Four: Informal Sales Channels and Revenue Tracking
A lot of peptide businesses start where their customers are, WhatsApp groups, Telegram channels, Instagram DMs, word of mouth. It’s scrappy and it works. But it creates a revenue tracking nightmare. When sales happen informally, invoicing is inconsistent. Payment terms are whatever the customer agreed to in a DM. Some customers pay immediately, some pay late, some pay in installments. Refunds and adjustments happen outside any formal system. And at the end of the month, nobody can tell you with confidence what revenue actually was.
What to do: get your sales into a system; any system, as early as possible. Even a simple invoicing platform that generates a record for every transaction is a massive improvement over informal channels. As you grow, that data becomes the foundation for everything: tax filings, lender conversations, investor due diligence, and your own understanding of what’s actually working.
Problem Five: Missing Controls and Undocumented Processes
Fast-growing businesses outgrow their processes before they build them. The founder does everything, knows everything, and makes every decision. It works until it doesn’t. Missing controls show up as missed billings, inconsistent pricing, expenses that don’t get categorized correctly, and vendor relationships that nobody manages because nobody owns them. Undocumented processes show up when the founder takes a week off or brings in their first employee and realizes that everything they know lives entirely in their head.
What to do: build the controls and documentation early, while the business is still small enough that it’s not painful. A simple set of standard operating procedures for your core financial processes, how sales get recorded, how expenses get approved, how the close gets done each month, is worth the investment before you need it rather than after something breaks.
Why We’re Building Here
We didn’t set out to specialize in peptide businesses. We set out to solve the financial problems that fast-moving, ambitious businesses face, the ones that traditional accounting firms haven’t always seen up close.
Turns out peptide companies have all of them. We work with businesses in regulated and high-risk categories, nutraceuticals, cannabis, and now peptides. The financial infrastructure challenges are consistent across all of them. And the solutions, while specific to each business, draw on the same body of experience.
If your books are a mess, your processor is unreliable, your personal and business finances are still entangled, or you’re not totally sure what your business actually looks like financially, that’s a solvable problem. And it’s worth solving sooner rather than later. We’re building a practice in this space. And we’re looking for the right businesses to grow with.
High Rock Accounting works with professional services firms, nutraceutical businesses, and high-risk DTC companies on financial strategy, bookkeeping, and operations. Interested in connecting? Reach out directly.
Enjoyed this article? Consider Sharing
Author
